NovaBay Pharmaceuticals (NBY) said Tuesday it has entered into an at-the-market sales agreement with Virtu Americas to sell up to $100 million of its shares from time to time.
Shares were down over 53% in recent trading.
Price: 6.83, Change: -7.95, Percent Change: -53.79
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments